# Aphena Pharma Solutions - Tennessee LLC – FDA Inspection, Nov 16, 2017

Source: https://www.keypedia.com/records/fda_inspections/aphena-pharma-solutions-tennessee-llc/cab1c194-a13e-4e74-83f5-9d05cf291828
Source feed: FDA_Inspections

> FDA inspection 1031560 of Aphena Pharma Solutions - Tennessee LLC, November 16, 2017. Classification: No Action Indicated (NAI). 3 citations under 21 CFR part 211. Form 483 issued. 14 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1031560
- Company Name: Aphena Pharma Solutions - Tennessee LLC
- Inspection Date: 2017-11-16
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Generic Drug Evaluation
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1295650 - 2025-11-03
- [FDA Inspection 1254447 - 2024-10-30](https://www.keypedia.com/records/fda_inspections/aphena-pharma-solutions-tennessee-llc/bcb93b05-6cb0-4f4c-9843-41b3321da316)
- FDA Inspection 1219353 - 2023-08-30
- FDA Inspection 1176357 - 2022-07-25
- FDA Inspection 1148356 - 2021-07-09

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/brandon-c-heitmeier/09e1b64b-01de-4f8b-819a-1179d8b4c0c1)

Company: https://www.keypedia.com/companies/aphena-pharma-solutions-tennessee-llc/69de5617-e85d-4684-a5af-8c1ceb15bb7f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c